REJUVANAD+ Trademark

Trademark Overview


On Friday, April 11, 2025, a trademark application was filed for REJUVANAD+ with the United States Patent and Trademark Office. The USPTO has given the REJUVANAD+ trademark a serial number of 79425415. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, April 27, 2026. The REJUVANAD+ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of age-related cellular decline; pharmaceutical preparations for anti-aging purposes; pharmaceutical preparations for cognitive enhancement and mental clarity; pharmaceutical preparations for boosting energy levels and treating fatigue; pharmaceutical preparations for supporting DNA repair; pharmaceutical preparations for cellular rejuvenation and metabolic support; pharmaceutical preparations for physical recovery; Pharmaceutical compositions, namely, nicotinamide adenine dinucleotide (NAD+) preparations for medical use; pharmaceutical compositions, namely, coenzyme preparations for medical use; pharmaceutical compositions, namely, anti-aging pharmaceutical preparations; Pharmaceutical drugs for the treatment of age-related cellular decline; pharmaceutical drugs for the treatment of fatigue; pharmaceutical drugs for the treatment of cognitive impairment; pharmaceutical drugs for the treatment of metabolic disorders; Cough pastilles for med...
rejuvanad+

General Information


Serial Number79425415
Word MarkREJUVANAD+
Filing DateFriday, April 11, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, April 27, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkREJUVANAD PLUS
Goods and ServicesPharmaceutical preparations for the treatment of age-related cellular decline; pharmaceutical preparations for anti-aging purposes; pharmaceutical preparations for cognitive enhancement and mental clarity; pharmaceutical preparations for boosting energy levels and treating fatigue; pharmaceutical preparations for supporting DNA repair; pharmaceutical preparations for cellular rejuvenation and metabolic support; pharmaceutical preparations for physical recovery; Pharmaceutical compositions, namely, nicotinamide adenine dinucleotide (NAD+) preparations for medical use; pharmaceutical compositions, namely, coenzyme preparations for medical use; pharmaceutical compositions, namely, anti-aging pharmaceutical preparations; Pharmaceutical drugs for the treatment of age-related cellular decline; pharmaceutical drugs for the treatment of fatigue; pharmaceutical drugs for the treatment of cognitive impairment; pharmaceutical drugs for the treatment of metabolic disorders; Cough pastilles for medical use; Medicinal infusions for treating fatigue and age-related conditions; Medicine preparations for human use for anti-aging purposes; medicine preparations for human use for cellular health support; medicine preparations for human use for the treatment of age-related conditions and fatigue; Non-prescription medicine preparations for general health and wellness support; non-prescription medicine preparations for anti-aging support; non-prescription medicine preparations for energy and vitality support; Pre-filled syringes containing nicotinamide adenine dinucleotide (NAD+) for medical purposes; prefilled syringes containing pharmaceutical preparations for anti-aging and cellular rejuvenation, for medical purposes; Pharmaceutical preparations for antiaging skin care; Anti-aging pharmaceutical compositions for skin care; Pharmaceutical preparations for skin care; Medicated skin care preparations for medical purposes; Medicated skin care preparations; Injectable dermal fillers for medical purposes; Medicated creams for skin care and protection of the skin

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 5, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressKR

Trademark Events


Event DateEvent Description
Thursday, June 5, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 6, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 6, 2025APPLICATION FILING RECEIPT MAILED
Monday, September 8, 2025ASSIGNED TO EXAMINER
Monday, September 8, 2025NON-FINAL ACTION WRITTEN
Tuesday, September 9, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 27, 2025REFUSAL PROCESSED BY MPU
Monday, October 27, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 15, 2025REFUSAL PROCESSED BY IB
Monday, April 27, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 27, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 27, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 27, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 27, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 27, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 27, 2026TEAS/EMAIL CORRESPONDENCE ENTERED